Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Improve Opioid Use Disorder Management by Changing Resident Training

By Rachel Haroz, MD; Alexis LaPietra, DO, FACEP; Stephen Holtsford, MD; and Reuben J. Strayer, MD | on October 23, 2020 | 2 Comments
ACEP4U
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Shutterstock.com

You Might Also Like
  • Five Steps to Help You Manage Opioid Use Disorder Patients
  • Few U.S. Doctors Can Legally Prescribe Buprenorphine
  • Treatment Strategies for Precipitated Opioid Withdrawal after Naloxone Rescue
Explore This Issue
ACEP Now: Vol 39 – No 10 – October 2020

Shutterstock.com

The last decade has witnessed a brutal toll of opioid-related suffering and deaths. Opioid addiction has shifted from a perceived moral failing confined to urban slums to one of accepted neurobiological disease pathology observed across geographic, racial, and socioeconomic lines. Medication-based treatment of opioid addiction reduces mortality and improves lives. Buprenorphine is safe and effective and can be initiated in the emergency department for patients with opioid use disorder (OUD).1 Significant barriers to treatment remain, however.

While buprenorphine can reduce mortality by two-thirds, only one out of three patients with OUD have access to this medication.2 Opioid use disorder has the highest short-term mortality of any acute disease we routinely treat in the emergency department, and it often occurs in young, otherwise healthy patients who, if moved to recovery, will go on to live long and productive lives. Due to stigma, however, addiction and addiction treatment have been siloed away from the rest of medicine. While we can have a substantial impact on our patients with OUD, we are much more comfortable treating heart disease, stroke, and sepsis. The work to bring OUD recognition and treatment into the purview of emergency medicine starts with the way we teach it to emergency medicine residents.

New Paradigm for a New Generation

Residency training is structured to systematically address the pathology and treatment of disease encountered in the emergency department. Residents are trained to make lifesaving diagnoses and perform complex procedures. This training gives little consideration to where the resident will eventually practice; the prevailing paradigm is that all emergency department doctors should be able to treat all life-threatening diseases in any acute care setting. 

As opioid deaths have skyrocketed over the last decade, emergency medicine residencies have largely continued to treat addiction according to the principles espoused since the specialty’s inception: provide a referral to outpatient addiction services and discharge the patient with a slap on the back. The data supporting the initiation of buprenorphine in the emergency department are clear and compelling, but most current EM residents have not received training on its use. This omission is a disservice to residents, patients, and the community at large.

Changing established behavior in practicing physicians is harder than learning a new concept in an unchartered space. Residents do not harbor the accumulated negative experiences from patient interactions resulting from poor addiction treatment of years past and can approach these challenging and stigmatized patients more easily, focusing on the disease rather than the behaviors. Today’s residents came of age during the opioid epidemic and are eager to be given the tools to manage it. They do not harbor the biases we developed and inherited from generations past and are less likely to develop stigmatized attitudes if trained to appropriately manage patients with substance use disorder.

Pages: 1 2 | Single Page

Topics: AddictionBuprenorphineOpioid Crisisopioid use disorderResidencyX waiver

Related

  • Pros and Cons: A Mandated Four-Year Residency

    June 11, 2025 - 1 Comment
  • Prehospital Buprenorphine Is a Powerful Tool in the Opioid-Crisis Fight

    June 4, 2025 - 0 Comment
  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

2 Responses to “Improve Opioid Use Disorder Management by Changing Resident Training”

  1. November 1, 2020

    TirEDoc Reply

    It’s difficult to “change physician behavior” on this issue because a lot of us who are more seasoned have seen the repeated failure of using an opiate based medication to treat OUD. Frankly it’s a bit suspect that this is being pushed as “a new trend” just because a pharmaceutical company has come up with a new drug that is “less addictive” than the industry’s previous formulations. I and many like me remain of the mindset to minimize patient exposure to opiate medications whenever possible, and support non-opiate detox programs which don’t support promulgation of some new drug now on the market.

  2. November 1, 2020

    John Herrick Reply

    I am all for this treatment, evidence based medicine, and harm reduction. Please just get rid of the waiver. Another merit badge in order to practice evidence based medicine is counter productive and further stigmatizes and limits buprenorphine’s use. I would not expect it to become standard of care until this hurdle is removed.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603